Derek Bates Lowe

Affiliations: 
Vertex Pharmaceuticals, Boston, MA, United States 
 Novartis, Basel, Basel-Stadt, France 
Area:
Medicinal chemistry
Website:
https://blogs.sciencemag.org/pipeline/
Google:
"Derek Lowe"
Bio:

https://en.wikipedia.org/wiki/Derek_Lowe_(chemist)
https://www.google.com/books/edition/Dissertation_Abstracts_International/yI8vAQAAIAAJ?hl=en&gbpv=1&bsq=rosaramicin
https://blogs.sciencemag.org/pipeline/archives/2010/10/28/shine_a_light
https://blogs.sciencemag.org/pipeline/archives/2009/12/15/manfred_christl_rides_again_bonus_idiotic_lab_accident_too

Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Ned A. Porter research assistant 1983 Duke
Bertram O. Fraser-Reid grad student 1988 Duke
 (Ph.D: "A carbohydrate-based approach to rosaramicin aglycon")
Bernd Giese post-doc 1988-1989 TU Darmstadt
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Come JH, Collier PN, Henderson JA, et al. (2018) Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ Inhibitors (PI3Kγ) with Potential for the Treatment of Multiple Sclerosis (MS). Journal of Medicinal Chemistry
Lowe DB. (2018) Introducing Biochemistry to Bedside. Biochemistry. 57: 469
Lowe DB. (2014) Drug discovery: Combichem all over again. Nature Chemistry. 6: 851-2
Lowe DB. (2012) Nowhere to go but up: the return of medicinal chemistry. Acs Medicinal Chemistry Letters. 3: 3-4
Rudolph J, Esler WP, O'connor S, et al. (2007) Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. Journal of Medicinal Chemistry. 50: 5202-16
Wood J, Bagi CM, Akuche C, et al. (2006) 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate. Bioorganic & Medicinal Chemistry Letters. 16: 4965-8
Lowe DB, Bifulco N, Bullock WH, et al. (2006) Substituted indanylacetic acids as PPAR-alpha-gamma activators. Bioorganic & Medicinal Chemistry Letters. 16: 297-301
Claus TH, Lowe DB, Liang Y, et al. (2005) Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose. The Journal of Pharmacology and Experimental Therapeutics. 315: 1396-402
Lowe DB, Magnuson S, Qi N, et al. (2004) In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase. Bioorganic & Medicinal Chemistry Letters. 14: 3155-9
See more...